文献速递性腺与生殖内分泌肥胖与代谢综合征糖尿病

多囊卵巢综合征研究是否经费不足

Perspectives on Polycystic Ovary Syndrome: Is Polycystic Ovary Syndrome Research Underfunded?
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该文利用美国国立卫生研究院(NIH)研究组合在线报告工具,比较2006至2015年PCOS与类风湿关节炎、结核病和系统性红斑狼疮的NIH资助情况。作者认为考虑PCOS患病率、经济负担和代谢疾病负担,其研究可能经费不足,并呼吁加强教育。

要点

  • PCOS全球患病率为4%至21%,具体取决于诊断标准。
  • 作者认为PCOS研究可能经费不足,需对NIH领导者等加强教育。

核心结论

  • 与RA、TB和SLE相比,PCOS获得的资助相对较少。
  • 作者认为,考虑到PCOS的患病率、经济负担、代谢疾病负担和对生活质量的负面影响,PCOS研究可能经费不足。
  • 需要专业学会、科学界和患者倡导者就PCOS对NIH领导者、其他联邦和州机构负责人、民选领导人和公众进行更多教育。

研究设计与样本

  • 使用NIH研究组合在线报告工具,检索NIH为PCOS及类风湿关节炎、结核病和系统性红斑狼疮授予的所有资助。
  • 比较2006至2015年(含)NIH对PCOS、RA、TB和SLE研究的资助。

主要发现

  • PCOS资助主要由一个NIH研究所/中心提供,而SLE和RA至少由两个研究所/中心提供。
  • RA、SLE和TB获得的个人研究项目资助数量多于PCOS,而PCOS资助更可能通过综合临床研究中心项目或专业中心项目奖项提供。

关键数值与推荐

  • PCOS全球患病率为4%至21%,取决于诊断标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Polycystic ovary syndrome (PCOS) is a common endocrine-metabolic abnormality with a worldwide prevalence of 4% to 21%, depending on diagnostic criteria. The National Institutes of Health (NIH) is the largest single funding agency in the world; it invests nearly $30.0 billion annually in biomedical research. EVIDENCE ACQUISITION: Using the NIH Research Portfolio Online Reporting tool, we searched for all grants awarded by the NIH for PCOS and three other disorders with similar degrees of morbidity and similar or lower mortality and prevalence [rheumatoid arthritis (RA), tuberculosis (TB), and systemic lupus erythematosus (SLE)]. EVIDENCE SYNTHESIS: We compared funding by the NIH for PCOS, RA, TB, and SLE research for the years 2006 to 2015, inclusive. CONCLUSION: PCOS, compared with RA, TB, and SLE, was relatively less funded (total mean 10-year funding was $215.12 million vs $454.39 million, $773.77 million, and $609.52 million, respectively). Funding for PCOS was largely provided by one NIH Institute/Center (ICs) vs at least two ICs for SLE and RA; more individual Research Project Grants were awarded for RA, SLE, and TB than for PCOS, whereas PCOS funding was more likely to be through General Clinical Research Centers Program or Specialized Centers Program awards. Our data suggest that PCOS research may be underfunded considering its prevalence, economic burden, metabolic morbidity, and negative impact on quality of life. Greater education of NIH leaders, including those at the National Heart, Lung, and Blood Institute and National Institutes of Diabetes and Digestive and Kidney Diseases; other federal and state agency leads; elected leaders; and the general public by professional societies, the scientific community, and patient advocates regarding this disorder is needed.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Brakta S, Lizneva D, Mykhalchenko K, et al. Perspectives on Polycystic Ovary Syndrome: Is Polycystic Ovary Syndrome Research Underfunded? J Clin Endocrinol Metab. 2017. PMID: 29092064. doi:10.1210/jc.2017-01415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。